Skip to main content
AAPS Open
Fig. 3 | AAPS Open

Fig. 3

From: Extraction of niclosamide from commercial approved tablets into aqueous buffered solution creates potentially approvable oral and nasal sprays against COVID-19 and other respiratory infections

Fig. 3

Baseline-corrected, 30 s subtracted spectra over 1–180 min dissolution for 300 µM fresh Yomesan niclosamide in nominal pH 9.35 Tris Buffer. The 30 s scan is shown as the dashed orange line and this 30 s scan was subtracted from each subsequent scan for 1 – 180 min. Each spectrum is an average of three scans (note: legend is ordered as 180 min to blank; graph is blank to 180 min)

Back to article page